Culver, K., Szechtman, H., 1997. Monoamine oxidase inhibitor sensitive site implicated in sensitization to quinpirole. Eur. J. Pharmacol. 339, 109-111.
Levant, B., Grigoradis, D., DeSouza, E., 1993. Monoamine oxidase inhibitors inhibit [3H]quinpirole binding in rat striatal membranes. Eur. J. Pharmacol. 246, 171-178.
Levant, B., Moehlenkamp J., Morgan K., Leonard L., Cheng C., 1996. Modulation of [3H]quinpirole binding in brain by monoamine oxidase inhibitors: Evidence for a potential novel binding site. J. Pharmacol. Exp. Ther. 278, 145-153.
Robinson, T., Becker, J., 1986. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res. 396, 157-198.
Szechtman, H., Talangbayan, H., Canaran, G., Dai, H., Eilam, D., 1994. Dynamics of behavioral sensitization induced by the dopamine agonist quinpirole and a proposed central energy control mechanism. Psychopharmacology 115, 95-104.
Szechtman, H., Culver, K., Eilam, D., 1999. Role of dopamine systems in obsessive-compulsive disorder (OCD): Implications from a novel psychostimulant-induced animal model. Pol. J. Pharm. 51, 55-61.
Culver, K., Rosenfeld, J, Szechtman H., 1999. A switch mechanism between locomotion and mouthing implicated in sensitization to quinpirole in rats. Psychopharmacology, submitted.
